○ We rigorously measured mutant allele frequency in cells of the father's lesional skin, father's blood and semen by next-generation sequencing.
○ We established the method to evaluate the risk of disease transmission as EI from the father having EN and to provide significant information at genetic counseling. There are various kinds of birthmarks. During we grow as an embryo, we get mutations in several genes in some cells of our bodies. It is thought that certain gene mutations in the cells of the skin could cause birthmarks. In many cases, birthmarks do not inherit because genes in sperm and eggs are rarely mutated, but in exceptional cases, it may be inherited to the next generation. In such cases, children develop the systemic form of skin symptoms identical to the birthmark.
EN, the subject of the present study, was a unique type of birthmarks due to mosaicism of KRT1 or KRT10 mutations. We encountered a family including a father with EN and his daughter with EI. We diagnosed daughter's disease by detection of heterozygous KRT10 mutation in her. Then, we investigated gDNA extracted from a skin sample from an EN lesion of her father and detected the identical mutation.
Considering the risk of EI in their future children, the parents wanted to know what percentage of the father's gametes had the mutation. Thus, we investigated the percentage of sperm with the pathogenic KRT10 mutation in a semen sample from the father by next-generation sequencing (NGS). We evaluated that approximately 3.9% of his sperm had the causative mutation.
In the present study, we investigated the precise prevalence of cells carrying the causative KRT10 mutation in the skin lesions, white blood cells in the peripheral blood, and the gametes of the EN patient by NGS. In cases of EN, genetic diagnosis of the skin lesion and proper genetic counseling on the risk of disease transmission to the next generation would be beneficial to patients who wish to bear children. A young Japanese girl, the proband, showed diffuse erythema, multiple blisters and erosions on the whole body at birth. With growth, she showed scales and hyperkeratosis on the entire body surface. She was clinically and histopathologically diagnosed with EI. Her father presented hyperkeratotic lesions on the upper limb and the lumbar regions. The affected skin accounted for 0.5% of his whole body surface.
First, mutation analysis identified a heterozygous mutation in KRT10 of genomic DNA (gDNA) from the proband. Then, we investigated gDNA extracted from the skin sample of the EN lesion of her father and detected the identical mutation. In considering future children, the parents wanted to know what percentage of the father's gametes had the mutation. Thus, we investigated the percentage of sperm with the pathogenic KRT10 mutation in semen from the proband's father by next-generation sequencing (NGS). We evaluated that approximately 3.9% of his semen had the causative mutation and that the mutant allele frequency in his peripheral blood was 5.3%, although we were unable to detect the mutation in either of the samples by Sanger sequencing.
These results clearly indicate the limited ability of Sanger sequencing to find low-level mosaicism. The mutant allele frequency in his lesional skin, including in the dermis, was 12.0%.
Research Summary and Future Perspective
We investigated the level of mosaicism in some tissues, including semen, by next-generation sequencing (NGS). From the mutant rates in sperm, we evaluated the risk of disease transmission from a father with EN to a child at future pregnancies. In cases of EN, genetic diagnosis of the skin lesion and proper genetic counseling on the
